Journal of Clinical Neuromuscular Disease · 2022 · 11 citations · 31 references
Life SciencesImmunologyInternal MedicineAutoimmunityImmunopharmacotherapyImmunotherapyImmunomodulatory DrugsMyasthenia GravisClinical RemissionImmunosuppressive CompoundsLong-term Efficacy AssessmentLong-term Efficacy EvaluationLong-term Remission MaintenanceMuscle-specific Kinase AntibodiesRetrospective Case StudyRituximab-based Therapy
OBJETIVE: Rituximab (RTX) is a therapeutic option, for patients with myasthenia gravis (MG) not responding to conventional immunosuppressive treatment. In this cohort, we evaluated long-term efficacy of RTX in the treatment of refractory generalized MG. METHODS: A retrospective study was performed in adult patients with refractory generalized MG and at least 24 months of follow-up, between January/2015 and October/2021. The Myasthenia Gravis Status and Treatment Intensity Score was used to assess outcomes, and CD19/CD20+ B-cell counts were monitored. RESULTS: Sixteen patients with MG (8 antiacetylcholine receptor+ and 8 muscle-specific antikinase+; mean age 45.5 ± 16.2 years) treated with low-dose RTX protocols were included. CD19/CD20 levels remained undetectable 12 months after induction, and no new relapses were observed during follow-up. CONCLUSIONS: Low-dose RTX infusions were sufficient to achieve undetectable CD19/20 cell counts and sustained clinical remission. In low and middle-income countries, the impact of low-dose RTX therapy represents a paradigm shift in decision-making for long-term treatment.
31
Long-lasting treatment effect of rituximab in MuSK myasthenia
Jordi Díaz‐Manera, Eugenia Martínez‐Hernández, Luís Querol et al. · Neurology · 2012 · 342 citations
Geraldine Cambridge, William Stohl, Maria Leandro et al. · Arthritis & Rheumatism · 2006 · 269 citations
Ted M. Burns, Mark R. Conaway, Donald B. Sanders · Neurology · 2010 · 255 citations · Full text
Rituximab as treatment for anti-MuSK myasthenia gravis
Michael K. Hehir, Lisa D. Hobson‐Webb, Michael Benatar et al. · Neurology · 2017 · 248 citations